TCT Liquid-Based Cytology Detection System

Liquid biopsy platform designed to detect and analyze circulating tumor cells in patient samples. Enables non-invasive cancer monitoring and personalized medicine applications through advanced genetic testing.

A next-generation circulating tumor cell detection system based on microfluidic chips and AI interpretation that captures cancer cells from a single blood sample. It enables non-invasive tumor monitoring, assists in lung nodule diagnosis, perioperative guidance, and treatment monitoring for precision oncology.

An independently developed liquid biopsy platform for detecting circulating tumor cells with high sensitivity and specificity. This non-invasive blood-based test provides comprehensive tumor-related information for malignant tumor diagnosis and treatment guidance.

Circulating Tumor Cell (CTC) detection products that identify and analyze tumor cells in patient blood samples. These products provide critical diagnostic information for cancer monitoring and treatment planning.

Thin-layer cytology test utilizing liquid-based preparation method for cervical cancer screening and detection of cellular abnormalities.

Liquid-based cervical cytology kit for standardized preparation and preservation of cervical cell samples in screening and diagnostic applications. Designed for use with digital pathology systems and AI-assisted cytology analysis to improve diagnostic accuracy in cervical cancer detection programs.

Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.

Liquid-based cytology kit combined with HPV detection for cervical cancer screening. The system integrates morphological assessment with molecular HPV testing for comprehensive cervical dysplasia evaluation.

Complete system for cervical cytology screening including collection and fixation components. Used for cervical cancer detection and prevention.

An automated cytology analysis platform that performs complete processing of cervical cells from staining through digital imaging to AI analysis. The system analyzes cell characteristics and provides results grouped by diagnostic categories for cervical cancer screening.

Liquid biopsy system for capturing and analyzing circulating tumor cells from patient blood samples. Reported capture efficiency of 73% for comprehensive tumor cell analysis in oncology applications.